[1]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2019/195720,2019,A1Locationinpatent:Page/Pagecolumn269
4778-25-0
55104-63-7
54224-26-9
1529441-82-4
157071-48-2
157071-50-6
1423033-87-7 | 1-amino-2,2,4-trimethylpentan-3-ol hydrochloride | AA01A2EI | MFCD22578581
100956-00-1 | 2-[4-(4-methoxyphenoxy)phenyl]ethan-1-amine hydrochloride | AA01A2IF | MFCD22578639
1249819-17-7 | 2-methyl-1-(pyrrolidin-2-ylmethyl)-1H-1,3-benzodiazole | AA01A2NP | MFCD16075762
1423029-73-5 | 4-tert-butyl-1,2,3,6-tetrahydropyridine hydrochloride | AA01A2RA | MFCD22628371
1249068-43-6 | 2-cyclobutoxypyridine-4-carbonitrile | AA01A2VP | MFCD16684465
59981-03-2 | (2S)-2-Aminopropanenitrile hydrochloride | AA01A2ZI | MFCD22628467
1094691-01-6 | quinolin-8-ylmethanesulfonamide | AA01A333 | MFCD11212982
2570-97-0 | 3-ethylheptanal | AA01A36Q | MFCD11553592
24786-56-9 | 5-bromo-1-ethyl-1H-1,3-benzodiazol-2-amine | AA01A3B9 | MFCD11868731
860745-87-5 | N-(4-amino-3-bromophenyl)acetamide | AA01A3EK | MFCD23144016